METHOD FOR PREDICTING RISK OF OR DETECTING FATTY LIVER DISEASE, REAGENT KIT AND BIOMARKER FOR DETECTING FATTY LIVER DISEASE, METHOD FOR DETERMINING RATE OF PROGRESSION OF LIVER FIBROSIS IN SUBJECT, AND BIOMARKER FOR DETERMINING RATE OF PROGRESSION OF LIVER FIBROSIS IN SUBJECT

摘要

The present invention addresses the problem of providing a novel method for diagnosing fatty liver disease that can be carried out more easily and that does not put a burden on patients or health care providers. The problem can be solved by measuring, in a body fluid sample, the amount of one or more long-chain acylcarnitines selected from the group consisting of octadecenoylcarnitine, tetradecenoylcarnitine, tetradecanoylcarnitine, hexadecanoylcarnitine, octadecanoylcarnitine, and octadecadienoylcarnitine, then comparing the result with a reference value.